Can Anti-Metastatic Albumin-based Superoxide Dismutase Mimetic Serve as a "Moonshot" Drug for Treatment for Brain Tumors - From Medulloblastoma to Glioblastoma?
Cell Biochem Biophys
.
2019 Jun;77(2):121-122.
doi: 10.1007/s12013-019-00869-2.
Epub 2019 May 15.
Authors
Carleton J C Hsia
1
,
Shanta M Messerli
2
,
W Keith Miskimins
3
Affiliations
1
AntiRadical Therapeutics LLC, Sioux Falls, SD, 57104, USA. chsia@nanorbc.com.
2
Cancer Biology and Immunotherapies, Sanford Research, Sioux Falls, SD, 57104, USA.
3
Cancer Biology and Immunotherapies, Sanford Research, Sioux Falls, SD, 57104, USA. keith.miskimins@sanfordhealth.org.
PMID:
31093886
DOI:
10.1007/s12013-019-00869-2
No abstract available
MeSH terms
Albumins
Brain Neoplasms*
Glioblastoma*
Humans
Medulloblastoma*
Superoxide Dismutase
Substances
Albumins
Superoxide Dismutase
Grants and funding
1R01CA180033-04/National Institutes of Health (US)/International
P20GM103548/GM/NIGMS NIH HHS/United States